A study presented at the EULAR 2016 conference showed for the first time a beneficial effect of estrogens in experimental models of skin fibrosis representative of the disease process in scleroderma. These findings may explain the increased incidence of the disease in women after menopause and men, and open up the possibility of developing hormone therapies for this difficult-to-treat condition.

Click here for more.